ArticleJournal of pain research2026
The Effectiveness of Fu's Subcutaneous Needling for Residual Pain After Percutaneous Vertebral Augmentation in Osteoporotic Vertebral Compression Fractures: A Randomized Clinical Trial Protocol.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Effectiveness of Fu's Subcutaneous Needling for Residual Pain After Percutaneous Vertebral Augmentation in Osteoporotic Vertebral Compression Fractures: A Randomized Clinical Trial Protocol [Letter].Journal of pain research · 2026Article
- The Effectiveness of Fu's Subcutaneous Needling for Residual Pain After Percutaneous Vertebral Augmentation in Osteoporotic Vertebral Compression Fractures: A Randomized Clinical Trial Protocol [Letter].Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporotic vertebral compression fractures (OVCFs) represent a significant cause of pain and functional disability in older adults. While vertebroplasty effectively alleviates acute pain and restores vertebral stability, a substantial proportion of patients experience persistent post-vertebroplasty residual pain. Emerging evidence indicates this pain is closely associated with myofascial injury and muscular dysfunction around the affected vertebrae. Fu's subcutaneous needling (FSN) has demonstrated efficacy in managing musculoskeletal pain; however, its safety and efficacy for post-vertebroplasty residual pain in OVCF patients remain understudied. This randomized controlled trial aims to evaluate the clinical efficacy of FSN in managing persistent post-procedural pain among patients following vertebroplasty, while exploring its underpinnings. Methods: This single-center, parallel-group, randomized controlled trial (RCT) will enroll 60 patients with osteoporotic vertebral compression fractures (OVCF) experiencing residual pain after vertebroplasty. Eligible participants will be randomly allocated in a 1:1 ratio to either Fu's subcutaneous needling (FSN) plus oral meloxicam therapy or meloxicam monotherapy. FSN determined three insertion points based on the patient's condition: (A) 2 cm lateral to the affected vertebra; (B) intersection of the umbilical plane and posterior axillary line; (C) midpoint of the posterior lower leg (between popliteal fossa and heel). Interventions will be administered once daily over seven consecutive days. The primary endpoint is the change from baseline in the Oswestry Disability Index (ODI) score at treatment completion. Secondary outcomes include: (i) Pain intensity (Visual Analog Scale, VAS); (ii) Lumbar function (Japanese Orthopaedic Association [JOA] score); (iii) Regional temperature differentials (infrared thermography); (iv) Serum inflammatory markers (IL-1β, IL-6, TNF-α); and (v) Incidence of treatment-emergent adverse events. Data will undergo intention-to-treat analysis with two-sided statistical testing (α=0.05; 95% confidence intervals).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.